The Role of the Pulmonary Vasculature in Heart Failure With Preserved Ejection Fraction

Journal of the American College of Cardiology

Volumn 53, Issue 13, 2009, Pages 1127-1129

  Lewis, Gregory D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

epidemiology; heart failure; pulmonary hypertension

Indexed keywords

DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION;

HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; STROKE VOLUME;

EID: 62549110390     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.01.006     Document Type: Editorial

References (31)

1. Simonneau G., Galie N., Rubin L.J., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 (2004) 5S-12S
2. Rich S., and Rabinovitch M. Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. Circulation 118 (2008) 2190-2199
3. Hadengue A., Benhayoun M.K., Lebrec D., and Benhamou J.P. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 100 (1991) 520-528
4. Mukerjee D., St George D., Coleiro B., et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62 (2003) 1088-1093
5. Mitchell H., Bolster M.B., and LeRoy E.C. Scleroderma and related conditions. Med Clin North Am 81 (1997) 129-149
6. Kessler R., Chaouat A., Weitzenblum E., et al. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J 9 (1996) 787-794
7. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37 (2001) 183-188
8. Butler J., Chomsky D.B., and Wilson J.R. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 34 (1999) 1802-1806
9. Braunwald E., Braunwald N.S., Ross Jr. J., and Morrow A.G. Effects of mitral-valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension. N Engl J Med 273 (1965) 509-514
10. Lam C.S.P., Roger V.L., Rodeheffer R.J., Borlaug B.A., Enders F.T., and Redfield M.M. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 53 (2009) 1119-1126
11. Ommen S.R., Nishimura R.A., Hurrell D.G., and Klarich K.W. Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study. Mayo Clin Proc 75 (2000) 24-29
12. McKee P.A., Castelli W.P., McNamara P.M., and Kannel W.B. The natural history of congestive heart failure: the Framingham study. N Engl J Med 285 (1971) 1441-1446
13. Lam C.S., Roger V.L., Rodeheffer R.J., et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 115 (2007) 1982-1990
14. Klapholz M., Maurer M., Lowe A.M., et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 43 (2004) 1432-1438
15. Zile M.R., Bennett T.D., St John Sutton M., et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 118 (2008) 1433-1441
16. McGoon M., Gutterman D., Steen V., et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 (2004) 14S-34S
17. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
18. Moraes D.L., Colucci W.S., and Givertz M.M. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 102 (2000) 1718-1723
19. Delgado J.F., Conde E., Sanchez V., et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail 7 (2005) 1011-1016
20. Stobierska-Dzierzek B., Awad H., and Michler R.E. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 38 (2001) 923-931
21. Bhat G., and Costea A. Reversibility of medically unresponsive pulmonary hypertension with nesiritide in a cardiac transplant recipient. ASAIO J 49 (2003) 608-610
22. Salzberg S.P., Lachat M.L., von Harbou K., Zund G., and Turina M.I. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg 27 (2005) 222-225
23. Franciosa J.A., Baker B.J., and Seth L. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J 110 (1985) 807-813
24. Lewis G.D., Shah R., Pappagianopoulos P.P., Systrom D.M., and Semigran M.J. Determinants of ventilatory efficiency in heart failure; the role of right ventricular performance and pulmonary vascular tone. Circ Heart Fail 1 (2008) 227-233
25. Arena R., Myers J., Abella J., et al. Development of a ventilatory classification system in patients with heart failure. Circulation 115 (2007) 2410-2417
26. Newman J.H., Phillips III J.A., and Loyd J.E. Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies. Ann Intern Med 148 (2008) 278-283
27. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781
28. Massie B.M., Carson P.E., McMurray J.J., et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359 (2008) 2456-2467
29. Guazzi M., Samaja M., Arena R., Vicenzi M., and Guazzi M.D. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol 50 (2007) 2136-2144
30. Lewis G.D., Shah R., Shahzad K., et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 116 (2007) 1555-1562
31. Behling A., Rohde L.E., Colombo F.C., Goldraich L.A., Stein R., and Clausell N. Effects of 5′-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. J Card Fail 14 (2008) 189-197